Peak Bio (PKBO) has issued an announcement.
David Rosenberg, Michael Friedman, and Stephen LaMond have abruptly resigned from their positions on the Board of Directors for personal reasons, with no disputes over the company’s operations or policies influencing their decision. Following their departure, the board has downsized to three members, streamlining its structure.
For detailed information about PKBO stock, go to TipRanks’ Stock Analysis page.
